Try it
Psychiatry · Perinatal psychiatry: postpartum depression neurosteroid
Sample itemWhich drug, a positive allosteric modulator of GABA-A receptors and an oral neurosteroid, is approved for postpartum depression?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Zuranolone
Zuranolone is an oral neuroactive steroid that modulates GABA-A receptors and is approved for postpartum depression in a 14-day course. Brexanolone is the intravenous form. Standard antidepressants like sertraline remain first-line for most women, and breastfeeding advice should be individualised.
Option by option
A. Fluoxetine
Fluoxetine is an SSRI and not a GABA-A modulator.
B. Zuranolone (correct)
Correct. Zuranolone is the oral GABA-A neurosteroid for postpartum depression.
C. Esketamine
Esketamine is an NMDA antagonist nasal spray.
D. Lithium
Lithium is a mood stabiliser.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Psychiatry questions
- PsychopharmacologyLithium use during the first trimester of pregnancy is associated with which congenital…
- Psychotic disordersWhich of the following is a Schneiderian first-rank symptom of schizophrenia?
- Organic psychiatryAn elderly patient on a surgical ward develops acute confusion that fluctuates through t…
- Eating disordersA 17-year-old girl has a BMI of 15, amenorrhoea, lanugo hair, bradycardia and an intense…